Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Completed · Phase 4 · Has a placebo group
Conditions studied: Bipolar Disorder, Cannabis-Related Disorder
In brief
The objectives of this study are to determine whether this treatment may be useful for reducing cannabis consumption; reducing symptoms of bipolar mania; and weight mitigation therapy for individuals on psychopharmacotherapy.
Key facts
- Study ID
- NCT00393978
- Run by
- University of Cincinnati
- People needed
- 75
- Starts
- 2006-11-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2017-09-26
Who can join
Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Cincinnati Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.